Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis
Chemical & Biomedical Imaging · 2025-11-24 · 3 (11) · 702-714
DOI: 10.1021/cbmi.5c00055 ↗At a glance
Übersichtsarbeit in Chemical & Biomedical Imaging, published online on 2025-07-10. Written by Xiuqi Hu and 6 co-authors. Institution: Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdiscip…. Cited 13 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Funding Program for Excellent Postdoctoral Talent.
Abstract (original language)
Liver fibrosis, a progressive condition marked by excessive extracellular matrix deposition and activation of hepatic stellate cells, often develops asymptomatically in its early stages, leading to delayed clinical intervention. Conventional imaging techniques typically fail to detect mild fibrosis, resulting in diagnosis only at advanced stages such as cirrhosis, when therapeutic efficacy is significantly compromised. Recent advances in molecular imaging have facilitated the development of targeted contrast agents that enhance diagnostic sensitivity by selectively binding to fibrosis-specific biomarkers or responding to pathological microenvironmental changes. These include both nonresponsive probes that accumulate in fibrotic tissue and activatable probes sensitive to enzymes, small molecules, and other fibrosis-associated signals. This review systematically summarizes these emerging strategies and evaluates their potential for improving early diagnosis, staging accuracy, and therapeutic monitoring, thereby guiding future development and applications in hepatic fibrosis management.
Subjects
Author keywords
Authors and institutions
- Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiologic…
- The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
ORCID profiles: Jianfeng Zeng
Funding
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Suzhou Fundamental Research Project
Cite
APA
Hu, X., Xu, M., Xiao, X., Wang, N., Zhang, Q., Ge, J., & Zeng, J. (2025). Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis. Chemical & Biomedical Imaging, 3(11), 702-714. https://doi.org/10.1021/cbmi.5c00055
Vancouver
Hu X, Xu M, Xiao X, Wang N, Zhang Q, Ge J, et al. Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis. Chemical & Biomedical Imaging. 2025;3(11):702-714. doi:10.1021/cbmi.5c00055
BibTeX
@article{Hu2025,
author = {Hu, Xiuqi and Xu, Mengdan and Xiao, Xiao and Wang, Ning and Zhang, Qianqian and Ge, Jianxian and Zeng, Jianfeng},
title = {Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis},
journal = {Chemical & Biomedical Imaging},
year = {2025},
volume = {3},
number = {11},
pages = {702--714},
doi = {10.1021/cbmi.5c00055}
}
EUVIMED